FDA: Risks of new asthma drugs vary
Saturday, December 6, 2008 - 14:28
in Health & Medicine
(AP) -- The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday.